| LDOS |
Report |
Revenue |
IN-LINE |
pred ~$4.420B vs. cons $4.444B |
MEDIUM |
| LDOS |
Report |
Non-GAAP diluted EPS |
IN-LINE |
pred ~$2.880 vs. cons $2.905 |
MEDIUM |
| LDOS |
Report |
Book-to-bill |
MISS |
pred ~0.95x vs. cons 1.022x |
LOW |
| LDOS |
Guide |
FY26 Revenue |
UNCHANGED |
guide $18.0B-$18.4B vs. cons $18.255B |
MEDIUM |
| LDOS |
Guide |
FY26 Non-GAAP EPS |
UNCHANGED |
guide $12.10-$12.50 vs. cons $12.314 |
MEDIUM |
| LDOS |
Guide |
FY26 Adjusted EBITDA Margin |
UNCHANGED |
guide mid-13s vs. cons 13.64% |
LOW |
| LDOS |
Guide |
FY26 Operating Cash Flow |
UNCHANGED |
guide approximately $1.8B vs. cons UNVERIFIED |
LOW |
| LDOS |
Guide |
H2 demand / awards commentary |
UNCHANGED |
reiterate Q2 trough and H2 acceleration vs. benchmark UNVERIFIED |
LOW |
| LDOS |
Return |
Day-1 residual (stock − beta × S&P 500) |
-2.0% |
— |
LOW |
| LDOS |
Return |
5-day cumulative residual |
-4.0% (FOLLOW-THROUGH) |
FOLLOW-THROUGH — in-line guide fails to offset a bookings miss after a strong run |
LOW |